Literature DB >> 1176969

Inhibition of the replication of influenza A and B viruses by a nucleoside analogue (ribavirin).

J S Oxford.   

Abstract

A synthetic nucleoside analogue 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboamide (ribavirin or RTCA) inhibits the replication of tissue culture of influenza B virus and also a wide range of influenza A viruses of human, animal and avian origin. The synthesis of influenza virus-induced antigens and also structural and non-structural polypeptides is inhibited by RTCA as detected by immunofluorescence and by pulse labelling experiments with [35S]-methionine. The inhibitory effects of RTCA on influenza A virus replication in tissue culture is reversed by a molar excess of guanosine or zanthosine which suggests that the compound acts at an early stage of virus RNA synthesis prior to the utilisation of the latter nucleosides. A possible inhibitory effect of RTCA on cellular DNA replication is not excluded.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1176969     DOI: 10.1099/0022-1317-28-3-409

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  24 in total

1.  Mechanism of action of T-705 against influenza virus.

Authors:  Yousuke Furuta; Kazumi Takahashi; Masako Kuno-Maekawa; Hidehiro Sangawa; Sayuri Uehara; Kyo Kozaki; Nobuhiko Nomura; Hiroyuki Egawa; Kimiyasu Shiraki
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

2.  Evaluation of the anti-influenza virus activities of 1,3,4-thiadiazol-2-ylcyanamide (LY217896) and its sodium salt.

Authors:  J M Colacino; D C DeLong; J R Nelson; W A Spitzer; J Tang; F Victor; C Y Wu
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

3.  Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate.

Authors:  B Eriksson; E Helgstrand; N G Johansson; A Larsson; A Misiorny; J O Norén; L Philipson; K Stenberg; G Stening; S Stridh; B Oberg
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

4.  Failure of type 1 herpesvirus to develop resistance to ribavirin.

Authors:  L B Allen; C M Fingal
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

5.  Inhibitory effect of a nucleotide analog on infectious salmon anemia virus infection.

Authors:  Andrea Rivas-Aravena; Eva Vallejos-Vidal; Marcelo Cortez-San Martin; Felipe Reyes-Lopez; Mario Tello; Patricia Mora; Ana María Sandino; Eugenio Spencer
Journal:  J Virol       Date:  2011-06-08       Impact factor: 5.103

6.  Effects of ribavirin on the development of the Friend leukemia.

Authors:  U Opitz; H J Seidel; G Streissle
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

7.  Enhancement of activity against influenza viruses by combinations of antiviral agents.

Authors:  F G Hayden; R G Douglas; R Simons
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

8.  Comparative activities of several nucleoside analogs against influenza A, B, and C viruses in vitro.

Authors:  S Shigeta; K Konno; T Yokota; K Nakamura; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

9.  Inhibition of influenza RNA synthesis by virazole (ribavirin).

Authors:  C Scholtissek
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

10.  Comparative activity of amantadine and ribavirin against influenza virus in vitro: possible clinical relevance.

Authors:  M J Browne; M Y Moss; M R Boyd
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.